| answer text |
<p>Trusts are obliged to charge the National Health Service the cost of the implantable
devices on a pass through basis, i.e. the cost invoiced by the supplier of the device.
The average prices have been issued to commissioners to help them assess value for
money on device expenditure and identify potential areas for future efficiency improvements.
NHS England’s current approach is not to impose a ceiling price however; we will be
working closely with providers where they are not taking advantage of current market
rates for devices.</p><p> </p>
|
 |
